[1]
Sleire, L.; Førde, H.E.; Netland, I.A.; Leiss, L.; Skeie, B.S.; Enger, P.∅. Drug repurposing in cancer; Pharma. Res, 2017, pp. 74-91.
[http://dx.doi.org/10.1016/j.phrs.2017.07.013] [PMID: 28712971]
[http://dx.doi.org/10.1016/j.phrs.2017.07.013] [PMID: 28712971]
[2]
Khachigian, L.M. Repurposing drugs for skin cancer. Curr. Med. Chem., 2020, 27(42), 7214-7221.
[http://dx.doi.org/10.2174/0929867327666191220103901] [PMID: 31858902]
[http://dx.doi.org/10.2174/0929867327666191220103901] [PMID: 31858902]
[3]
Torralba, M.; Farra, R.; Maddaloni, M.; Grassi, M.; Dapas, B.; Grassi, G. Drugs repurposing in high-grade serous ovarian cancer. Curr. Med. Chem., 2020, 27(42), 7222-7233.
[http://dx.doi.org/10.2174/0929867327666200713190520] [PMID: 32660396]
[http://dx.doi.org/10.2174/0929867327666200713190520] [PMID: 32660396]
[4]
Fernandes, S.; Cassani, M.; Pagliari, S.; Filipensky, P.; Cavalieri, F.; Forte, G. Tumor in 3D: in vitro complex cellular models to improve nanodrugs cancer therapy. Curr. Med. Chem., 2020, 27(42), 7234-7255.
[http://dx.doi.org/10.2174/0929867327666200625151134] [PMID: 32586245]
[http://dx.doi.org/10.2174/0929867327666200625151134] [PMID: 32586245]
Current Medicinal Chemistry
Title:Drug Repurposing in Human Cancers
Volume: 27 Issue: 42
Author(s): Gabriele Grassi and Mario Grassi
Affiliation:
Export Options
About this article
Cite this article as:
Grassi Gabriele and Grassi Mario , Drug Repurposing in Human Cancers, Current Medicinal Chemistry 2020; 27 (42) . https://dx.doi.org/10.2174/092986732742201105104417
DOI https://dx.doi.org/10.2174/092986732742201105104417 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
12
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?
Reviews on Recent Clinical Trials Self-Assembled Micelles of Amphiphilic PEGylated Drugs for Cancer Treatment
Current Drug Targets The Role of PARP Inhibitors in the Treatment of Ovarian Carcinomas
Current Pharmaceutical Design Targeting Cell Death in Tumors by Activating Caspases
Current Cancer Drug Targets Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Recent Patents on Anti-Cancer Drug Discovery Tyrosine Kinase Update: Role and Response in Cancer Therapy
Current Cancer Therapy Reviews Clinical Pharmacogenetics in Oncology: the Paradigm of Molecular Targeted Therapies
Current Pharmaceutical Design Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Perspectives on Medicinal Properties of Mangiferin
Mini-Reviews in Medicinal Chemistry Approaches to Improve Cellular Retention of Radiohalogen Labels Delivered by Internalising Tumour-Targeting Proteins and Peptides
Current Medicinal Chemistry Pharmaco-Therapeutic Challenges in Cancer Biology with Focus on the Immune- System Related Risk Factors
Current Pharmaceutical Design Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Current Enzyme Inhibition Approaches for the Inhibition of Human Telomerase Based on the Use of Peptide Nucleic Acids and Hammerhead Ribozymes
Mini-Reviews in Medicinal Chemistry Techniques and Methods for In Vivo MRI Monitoring of Exogenous and Endogenous Neural Stem Cell-Mediated Brain Repair
Recent Patents on Regenerative Medicine Effective Inhibition of Foam Cells Formation by Tanshinone IIA in RAW264.7 Macrophages Induced with LDL Isolated from Hypercholesterolemia Patients: A Proteomic Analysis
Current Proteomics Anti-Proliferative, Anti-Inflammatory, Anti-Ulcerogenic and Wound Healing Properties of Chitosan
Current Bioactive Compounds Novel Applications of the Paired-End diTag (PET) Technology in Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Effect of Lapachol on the Inhibition of Matrix Metalloproteinase Related to the Invasion of Human Fibrosarcoma Cells
Current Molecular Pharmacology Role of Graphene Nano-Composites in Cancer Therapy: Theranostic Applications, Metabolic Fate and Toxicity Issues
Current Drug Metabolism Investigating the In Vivo Expression Patterns of miR-7 microRNA Family Members in the Adult Mouse Brain
MicroRNA